Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Adjuvant Intraarterial Chemotherapy Following Surgery to Treat Locally Advanced Bladder Cancer

NCT01627197

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

NCT04504669

Conditions: Adenocarcinoma, Advanced Solid Tumours, Breast Diseases, +48 more
Locations: Research Site Baltimore, Maryland, United States

Research Site St Louis, Missouri, United States

Research Site Huntersville, North Carolina, United States

Research Site Franklin, Tennessee, United States

View all 13 locations

View Trial Details

Completed

MEDI4736 Combinations in Metastatic Renal Cell Carcinoma

NCT02819596

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Thomas Powles London, United Kingdom

View Trial Details

Completed

A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology

NCT01672775

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: Site US00005 University of Michigan Medical Center Ann Arbor, Michigan, United States

Site US00003 Karmanos Cancer Institute Detroit, Michigan, United States

Site US00004 Roswell Park Cancer Institute Buffalo, New York, United States

Site US00002 Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients

NCT06657755

Conditions: Bladder (Urothelial, Transitional Cell) Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Lanzhou University Second Hospital Lanzhou, Gansu, China

View Trial Details

Completed

A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma

NCT06656039

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Renji Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

NCT04883827

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Tennessee Valley Health Care System Nashville, Tennessee, United States

Vanderbilt University Medical Center Nashville, Tennessee, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-associated Fatigue

NCT06648902

Conditions: Fatigue Related to Cancer Treatment, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Megis medical clinic Tirana, Albania

National Center of Oncology Baku, Azerbaijan

STOONCO clinic Moscow, Russia

View Trial Details

Completed

Effect of Tumor Base Size in Bladder Cancer

NCT06632340

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Ankara Training and Research Hospital Ankara, Turkey (Türkiye)

View Trial Details

Completed

Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer

NCT06337305

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions